Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

38.68
Delayed Data
As of Aug 21
 -0.07 / -0.18%
Today’s Change
37.20
Today|||52-Week Range
44.54
+0.44%
Year-to-Date

Today’s Trading

Previous close38.75
Today’s open38.75
Day’s range38.60 - 38.82
Volume2,051,734
Average volume (3 months)2,811,419
Market cap$95.1B
Dividend yield6.43%
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+13.93%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+2.85%
P/E ratio49.1
Price/Sales2.52
Price/Book67.78

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.22+0.39%
CELGCelgene-0.22-0.17%
NVONovo Nordisk+0.28+0.62%
LLYEli Lilly and Co+0.31+0.40%
Data as of 08/21/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts